144 related articles for article (PubMed ID: 8887886)
1. Changes in tissue contents of zinc, copper and iron in rats and beagle dogs treated with polaprezinc.
Yamaguchi I; Shibata K; Takei M; Matsuda K
J Toxicol Sci; 1996 Aug; 21(3):177-87. PubMed ID: 8887886
[TBL] [Abstract][Full Text] [Related]
2. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
[TBL] [Abstract][Full Text] [Related]
3. Tissue distribution of polaprezinc in rats determined by the double tracer method.
Furuta S; Suzuki M; Toyama S; Miwa M; Sano H
J Pharm Biomed Anal; 1999 Mar; 19(3-4):453-61. PubMed ID: 10704111
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of the novel anti-peptic ulcer agent polaprezinc in beagle dogs.
Matsuda K; Yamaguchi I; Wada H
Arzneimittelforschung; 1995 Jan; 45(1):52-60. PubMed ID: 7893270
[TBL] [Abstract][Full Text] [Related]
5. Disposition of polaprezinc (zinc L-carnosine complex) in rat gastrointestinal tract and effect of cimetidine on its adhesion to gastric tissues.
Furuta S; Toyama S; Miwa M; Sano H
J Pharm Pharmacol; 1995 Aug; 47(8):632-6. PubMed ID: 8583362
[TBL] [Abstract][Full Text] [Related]
6. Oral treatment of pressure ulcers with polaprezinc (zinc L-carnosine complex): 8-week open-label trial.
Sakae K; Yanagisawa H
Biol Trace Elem Res; 2014 Jun; 158(3):280-8. PubMed ID: 24691900
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
Himoto T; Hosomi N; Nakai S; Deguchi A; Kinekawa F; Matsuki M; Yachida M; Masaki T; Kurokochi K; Watanabe S; Senda S; Kuriyama S
Scand J Gastroenterol; 2007 Sep; 42(9):1078-87. PubMed ID: 17710674
[TBL] [Abstract][Full Text] [Related]
8. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats.
Kono T; Asama T; Chisato N; Ebisawa Y; Okayama T; Imai K; Karasaki H; Furukawa H; Yoneda M
Life Sci; 2012 Jan; 90(3-4):122-30. PubMed ID: 22100444
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of the novel anti-peptic ulcer agent catena-(S)-[mu-[Na- (3-aminopropionyl)histidinato(2-)-N1,N2,Q:N tau]-zinc in male cynomolgus monkeys.
Green OP; Deoraj P; Gopinath C; Crook D; Matsuda K
Arzneimittelforschung; 1993 May; 43(5):562-9. PubMed ID: 8329001
[TBL] [Abstract][Full Text] [Related]
10. Preventive effect of zinc compounds, polaprezinc and zinc acetate against the onset of hepatitis in Long-Evans Cinnamon rat.
Sugawara N; Katakura M; Sugawara C
Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):167-76. PubMed ID: 10461683
[TBL] [Abstract][Full Text] [Related]
11. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
[TBL] [Abstract][Full Text] [Related]
12. Irritant action of monochloramine in rat stomachs: effects of zinc L-carnosine (polaprezinc).
Nishiwaki H; Kato S; Takeuchi K
Gen Pharmacol; 1997 Nov; 29(5):713-8. PubMed ID: 9347315
[TBL] [Abstract][Full Text] [Related]
13. Effect of polaprezinc on taste disorders in zinc-deficient rats.
Hamano H; Yoshinaga K; Eta R; Emori Y; Kawasaki D; Iino Y; Sawada M; Kuroda H; Takei M
Biofactors; 2006; 28(3-4):185-93. PubMed ID: 17473379
[TBL] [Abstract][Full Text] [Related]
14. Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats.
Hamano H; Yoshinaga K; Tanaka T; Eta R; Horii T; Kawabata Y; Furuta S; Takei M
Life Sci; 2009 Nov; 85(21-22):759-64. PubMed ID: 19846043
[TBL] [Abstract][Full Text] [Related]
15. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats.
Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K
J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547
[TBL] [Abstract][Full Text] [Related]
16. Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice.
Ohkawara T; Takeda H; Kato K; Miyashita K; Kato M; Iwanaga T; Asaka M
Scand J Gastroenterol; 2005 Nov; 40(11):1321-7. PubMed ID: 16334442
[TBL] [Abstract][Full Text] [Related]
17. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc.
Nishiwaki H; Kato S; Sugamoto S; Umeda M; Morita H; Yoneta T; Takeuchi K
J Physiol Pharmacol; 1999 Jun; 50(2):183-95. PubMed ID: 10424716
[TBL] [Abstract][Full Text] [Related]
18. [Development of polaprezinc research].
Takei M
Yakugaku Zasshi; 2012; 132(3):271-7. PubMed ID: 22382829
[TBL] [Abstract][Full Text] [Related]
19. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate.
Kato S; Nishiwaki H; Konaka A; Takeuchi K
Dig Dis Sci; 1997 Oct; 42(10):2156-63. PubMed ID: 9365151
[TBL] [Abstract][Full Text] [Related]
20. The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide.
Choi HS; Lim JY; Chun HJ; Lee M; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS; Sul D
Life Sci; 2013 Jul; 93(2-3):69-77. PubMed ID: 23743168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]